0001387131-15-003566.txt : 20151208 0001387131-15-003566.hdr.sgml : 20151208 20151208143721 ACCESSION NUMBER: 0001387131-15-003566 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151207 FILED AS OF DATE: 20151208 DATE AS OF CHANGE: 20151208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 682-8452 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slakter Jason Scott CENTRAL INDEX KEY: 0001630109 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 151275428 MAIL ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 4 1 slakter-form4_120715.xml OWNERSHIP DOCUMENT X0306 4 2015-12-07 0 0001173281 Ohr Pharmaceutical Inc OHRP 0001630109 Slakter Jason Scott C/O OHR PHARMACEUTICALS INC. 800 THIRD AVENUE, 11TH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 100 4.13 A 506246 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 1200 4.12 A 507446 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 100 4.10 A 507546 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 300 4.07 A 507846 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 300 4.05 A 508146 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 800 4.02 A 508946 D Common Stock, par value $0.0001 per share 2015-12-07 4 P 0 200 4.00 A 509146 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2015. /s/ Jason Scott Slakter 2015-12-08